Circulating omentin as a novel biomarker of endothelial dysfunction

Area of Science:

• Endocrinology
• Cardiovascular Research
• Metabolic Syndrome

Background:

• Omentin, a novel soluble lectin from visceral adipose tissue, exhibits vasodilator properties.
• Obesity is linked to cardiovascular risk factors, necessitating investigation into associated biomarkers.
• Understanding the interplay between omentin, metabolic health, and endothelial function is crucial.

Purpose of the Study:

• To investigate the relationship between circulating omentin levels and metabolic parameters.
• To explore the association between omentin, insulin sensitivity, and endothelial function.
• To determine if omentin is an independent predictor of endothelial function in men with varying glucose tolerance.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to measure circulating omentin in 248 white men.
• Participants were categorized into normal glucose tolerance (NGT) and impaired glucose tolerance (IGT) groups.
• Insulin sensitivity (IVGTT) and vascular reactivity (brachial artery ultrasound) were assessed.

Main Results:

• Omentin levels were significantly higher in lean individuals compared to overweight and obese subjects.
• Circulating omentin correlated with BMI, waist-to-hip ratio, blood pressure, inflammatory markers (CRP, IL-6), and vasodilation.
• In IGT subjects, omentin independently predicted endothelium-dependent vasodilation (EDV), alongside systolic blood pressure and BMI.

Conclusions:

• Circulating omentin concentration is inversely associated with obesity and positively associated with endothelial function.
• Omentin may serve as a valuable biomarker for assessing endothelial health, particularly in individuals with metabolic disturbances.
• Further research can elucidate omentin's role in the pathogenesis of obesity-related cardiovascular complications.